Clinical Trial Update: Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the impact of epoetin alfa on hemoglobin, symptom distress, and quality of life in patients receiving chemotherapy. The trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Drugs mentioned

• Epoetin alfa (Epogen) (epoetin alfa)

Snippet

Sponsor: Ortho Biotech, Inc. | Conditions: Chemotherapy, Anemia | Phase 4 | Status: COMPLETED